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Abstract
Sepsis results in a profound state of immunosuppression, which is temporally associated with impaired leukocyte function.
The mechanism of leukocyte reprogramming in sepsis is incompletely understood. In this study, we explored mechanisms
contributing to dysregulated inflammatory cytokine expression by pulmonary macrophages during experimental sepsis.
Pulmonary macrophages (PM) recovered from the lungs of mice undergoing cecal ligation and puncture (CLP) display
transiently reduced expression of some, but not all innate genes in response to LPS. Impaired expression of TNF-a and iNOS
was associated with reduced acetylation and methylation of specific histones (AcH4 and H3K4me3) and reduced binding of
RNA polymerase II to the promoters of these genes. Transient impairment in LPS-induced cytokine responses in septic PM
temporally correlated with induction of IRAK-M mRNA and protein, which occurred in a MyD88-dependent fashion. PM
isolated from IRAK-M
2/2 mice were largely refractory to CLP-induced impairment in cytokine expression, chromatin
remodeling, recruitment of RNA polymerase II, and induction of histone deacetylase-2 observed during sepsis. Our findings
indicate that systemic sepsis induces epigenetic silencing of cytokine gene expression in lung macrophages, and IRAK-M
appears to be a critical mediator of this response.
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Introduction
Sepsis results in profound suppression of both innate and
acquired immune responses [1,2,3]. This syndrome influences the
effector activity of a variety of immune cells, including blood
monocytes, tissue macrophages, neutrophils, dendritic cells, and
lymphocytic populations [2,4,5,6,7]. Alterations in monocyte/
macrophage function during sepsis include impaired responsive-
ness to LPS and other pathogen associated molecular patterns
(PAMPs), resulting in reduced inflammatory cytokine production,
adhesion molecule expression, respiratory burst, and production of
reactive nitrogen species [5,6,7,8,9,10,11]. The reprogramming of
effector responses in septic macrophages resemble but are not
identical to that observed in endotoxin-tolerized macrophages,
whereby initial exposure to LPS renders cells refractory to a
subsequent LPS challenge. Phenotypic changes in macrophages
during sepsis are often transient, and failure to reverse this
deactivated state has been associated with worse clinical outcomes
in sepsis patients [5,7,10,11].
The mechanisms accounting for sepsis-induced deactivation
and endotoxin tolerance are incompletely defined, but are
characterized by impaired toll-like receptor (TLR) mediated
activation of both NF-kB- and mitogen-activated protein kinase
(MAPK)-dependent genes [5,9,10]. Interleukin-1 receptor-associ-
ated kinase-M (IRAK-M; also referred to as IRAK-3) is a protein
in the IRAK family that has been shown to be an important
negative regulator of TLR-mediated cell signaling [12,13,14]. In
contrast to IRAK-1 and IRAK-4, IRAK-M lacks kinase activity
and negatively regulates signaling through MyD88-dependent
TLRs [14]. This protein has been shown to regulate critical
aspects of innate immunity, including the development of
endotoxin tolerance and sepsis-induced alterations of antimicro-
bial responses [14,15,16,17,18]. IRAK-M was initially believed to
be limited to cells of monocytic lineage. However, we and others
have shown that cells of both hematopoetic and non-hematopoetic
origin express biologically active IRAK-M [1,18,19,20]. The role
of this inhibitory protein in regulating key aspects of cytokine gene
expression during sepsis has been incompletely defined.
Gene expression is not only dictated by the genetic code, but
also by epigenetic alterations of chromatin that can substantially
modify gene expression in either an inheritable or transient fashion
[21]. For example, methylation of cysteine residues within CpG
islands of promoter regions can function to suppress gene
activation [22]. Moreover, post-translational chemical modifica-
tion of histones binding to promoter regions of DNA regulate
access of DNA to transcription factors, regulatory proteins or
RNA polymerase required for gene transcription [23,24].
Examples include acetylation of histone 4 or trimethylation of
lysine 4 of histone 3 (H3K4me3) generally enhances access to
DNA leading to gene activation, whereas di-or tri-methylation of
lysine 27 of histone 3 closes DNA resulting in a gene silencing
effect [24,25]. Endotoxin tolerance has been associated with
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tolerizable genes [26,27]. Likewise, a decrease in activating histone
PTMs (i.e. H3K4me3) and concomitant increase in suppressive
PTMs (H3K27me3) has been noted in dendritic cells isolated from
mice out to 6 weeks after induction of sepsis [28]. The contribution
of histone PTMs to altered monocyte/macrophage effector
responses in sepsis have not been described.
In this study, we investigated the role of IRAK-M in regulating
lung macrophage effector responses during sepsis, and determined
if this key protein might regulate gene expression by altering
critical histone PTMs in septic lung macrophages.
Methods
Ethical Statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by University
Committee on Use and Care of Animals at the University of
Michigan (UCUCA approval number 09721).
Mice
Colonies of IRAK-M
2/2 and MyD88
2/2 mice bred on a B6
background were established at the University of Michigan [15].
Age- and sex-matched specific pathogen–free 5- to 8-week-old
C57BL/6J mice were purchased from the Jackson Laboratory (Bar
Harbor, Maine). All animals were housed in specific pathogen–
free conditions within the University of Michigan animal care
facility (Ann Arbor, Michigan, USA) until the day of sacrifice. All
animal experiments were performed in accordance with NIH
policies on the humane care and use of laboratory animals and
approved by the University Committee on Use and Care of
Animals (UCUCA) at the University of Michigan.
Cecal ligation and puncture (CLP)
CLP was used as a model of systemic sepsis syndrome as
previously described [8,15]. Pathogen-free C57BL/6 mice were
anesthetized with a mixture of i.p. xylazine and ketamine. A 1-cm
longitudinal incision was made to the lower-right quadrant of the
abdomen and the cecum exposed. The distal one-third of the cecum
was ligated with a 3-0 silk suture and punctured through with a 26-
gauge needle. Puncture with this gauge needle results in a marked
septic response but with death occurring in 0–10% of animals. The
cecumwas then placed backinthe peritonealcavity, andthe incision
was closed with surgical staples. In sham surgical controls, the cecum
was exposed but not ligated or punctured, then returned to the
abdominal cavity. All mice were administered 1 ml of sterile saline
s.c.forfluid resuscitationduring theimmediate postoperativeperiod.
Total lung leukocyte preparation by lung digest
Lungs were removed from euthanized animals and leukocytes
prepared as previously described [15]. Briefly, lungs were minced
with scissors to fine slurry in 15 ml of digestion buffer (RPMI, 10%
fetal calf serum, 1 mg/ml collagenase [Roche Diagnostics], 30 mg/
ml DNase [Sigma-Aldrich]) per lung. Lung slurries were enzymat-
ically digested for 30 minutes at 37uC. Any undigested fragments
were further dispersed by drawing the solution up and down
through the bore of a 10-ml syringe. The total lung cell suspension
waspelleted,resuspended,and spunthrougha40%Percollgradient
to enrich for leukocytes. Cell counts and viability were determined
using Trypan blue exclusion counting on a hemacytometer.
Cytospin slides were prepared and stained with a modified
Wright-Giemsa stain. Cells were then cultured in RPMI with or
without 100 ng/mL LPS (Sigma-Aldrich, USA). Adherent PM
were washed and lysed for RNA isolation. Confirmation of purity of
macrophage cultures was determined by flow cytometry using light
scatter characteristics and expression of CD45 and CD11b. Cells
were .95% macrophages using this isolation technique.
Real-time quantitative RT-PCR
Measurement of gene expression was performed utilizing the ABI
Prism 7000 Sequence Detection System (Applied Biosystems) as
previously described [15]. Briefly, the primers and probe for b-actin
was designed using Primer Express software (Applied Biosystems).
The primers, placed in different exons, were tested to ensure that
they do not amplify genomic DNA. Primers and probe nucleotide
sequences for mTNF-a were as follows: forward 59-CAGCC-
GATGGGTTGTACCTT-39, reverse 59-TGTGGGTGAGGAG-
CACGTAGT-39, probe 59-TCCCAGGTTCTCTTCAAGGGA-
CAAGGC-39; for mIL-12p40: forward 59-AGACCCTGCCCA-
TTGAACTG-39, reverse 59-GAAGCTGGTGCTGTAGTTCT-
CATATT-39, probe 59-CGTTGGAAGCACGGCAGCAGAA-39;
for mIRAK-M: forward 59-TGAGCAACGGGACGCTTT-39,
reverse 59-GATTCGAACGTGCCAGGAA-39, probe 59-TTA-
CAGTGCACAAATGGCACAACCCC-39; miNOS forward, 59-
CCCTCC TGA TCT TGT GTT GGA-39; reverse, 59-CAA CCC
GAG CTC CTG GAA-39; and probe, 59-TGA CCA TGG AGC
ATC CCA AGT ACG AGT-39; for mLcn2 forward, 59-GG-
GCAGGTGGTACGTTGTG-39; reverse, 59-CAT CGT AAA
GCT GCC TTC TGTTT-39; and probe, 59-CCTGGCAGG-
CAATGCGGTCC-39;for mHDAC-1 forward 59-CTGGGAG-
GAGGTGGCTACAC-39, reverse 59-GCCACCGCTGTTTCG-
TAAGT-39, and probe 59-ATCCGGAATGTTGCTCGCTGC-
TG-39; for mHDAC-2: forward 59-GAAGATTGTCCGGTG-
TTTGATG-39, reverse 50-CACAGCCCCAGCAACTGAA-39,a n d
probe 59-ACTCTTTGAGTTTTGTCAGCTCTCCACGGG-39for
mHDAC-3: forward 59-CCCAGTGTCCAGATTCATGATG-39,
reverse 59-GGCCTCGTCAGTCCTGTCA-39,a n dp r o b e5 9-
CCCGGCAGACCTCCTGACGT-39 for mHDAC-7: forward 59-
CTTTCCCTTGCGTAAAACAGTGT-39, reverse 59-GCGTCTC-
TCCAGGGATTTCTT, and probe 59-CCCAACCTGAAGT-
TGCGCTACAAACC-39;f o rm b-actin: forward 59-CCGTGAAAA-
GATGACCCAGATC-39, reverse 59-CACAGCCTGGATGGC-
TACGT-39,p r o b e5 9-TTTGAGACCTTCAACACCCCAGCCA-
39. Specific thermal cycling parameters used with the TaqMan One-
Step RT-PCR Master Mix Reagents kit (Applied Biosystems,
USA) included 30 minutes at 48uC, 10 minutes at 95uC, and 40
cycles involving denaturation at 95uC for 15 seconds, annealing/
extension at 60uC for 1 minute. Relative quantitation of cytokine
mRNA levels was plotted as fold change relative to untreated
control cells of the lung. All experiments were performed in
triplicate.
Chromatin Immunoprecipitation Assay (ChIP)
Lung macrophages were isolated as described above. The
chromatin immunoprecipitation (ChIP) procedure was performed
using a modification of an assay kit (Upstate Biotechnology,
Charlottesville,VA) according to the manufacturer’s instructions
[28]. Briefly, 2–3610
6 isolated PM were treated with vehicle or
LPS 1 mg/mL for 2–4 hours. DNA-protein structure was then
cross-linked by 1% formaldehyde for 10 minutes at 37uC. Cells
were collected and lysed in 400 mL SDS lysis buffer. The resulting
lysates were sonicated to obtain DNA fragments ranging from 200
to 1000 bp (base pairs) using a Branson Sonifier 450 (VWR, West
Chester, PA) six times for periods of 15 seconds each. After
centrifuging, the supernatant containing chromatin was diluted,
and an aliquot (2% volume) was saved to indicate the input DNA
in each sample. The remaining chromatin fractions were pre-
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followed by immunoprecipitation with the following antibodies:
anti-acetyl histone H4 (Upstate Biotechnology), anti-H3K4me3
(Upstate), or anti-RNA polymerase II (Santa Cruz Biotechnology)
overnight at 4uC with gentle rotation. Cross-linking was reversed
for 4 hours at 65uC and was followed by proteinase K digestion.
DNA was purified by standard phenol/chloroform and ethanol
precipitation and was subjected to real-time PCR. Primers for
mTNF-a promoter are as follows: forward, GGAAATAGACA-
CAGGCATGGTCT; reverse, CCTACACCTCTGTCTCGGT-
TTCTT; iNOS promoter: forward, CCTCCCCAGAACTTAT-
TGCAAG; reverse GAAAAT CCCCCTAGCACATCCT. Data
was expressed as percent of input DNA or fold increase over
unstimulated cells.
Immunoflorescence staining for IRAK-M
Lung macrophages were isolated as described above. The cells
were permeablized with a 1:1 mixture of methanol and acetone.
After washing with PBS, anti-IRAK-M antibodies (abcam) were
applied and the cells incubated in their presence for one hour.
After washing, antibodies against the primary antibody labeled
with FITC were applied to the cells and incubated for one hour.
The cell were then mounted in DAPI mounting media and viewed
on the fluorescent microscope
Western immunoblotting for HDAC-2 expression
Whole cell lysates were obtained by treating cells with RIPA
buffer (1% w/w NP-40, 1% w/v sodium deoxycholate, 0.1% w/v
SDS, 0.15 M NaCl, 0.01 M sodium phosphate, 2 mM EDTA,
and 50 mM sodium fluoride) plus protease and phosphatase
inhibitors. Protein concentrations were determined by the Bio-
Rad DC protein assay (Bio-Rad Laboratories, Hercules, CA).
Samples were electrophoresed in 4–12% gradient SDS-PAGE
gels, transferred to nitrocellulose and blocked with 5% skim milk
in PBS. After incubation with primary anti-HDAC-2 Ab (Cell
Signalling), blots were incubated with secondary antibody linked
to horseradish peroxidase and bands visualized using enhanced
chemiluminescence (SuperSignal West Pico Substrate, Pierce
Biotechnology, Inc., Rockford, IL).
Statistical analysis
Statistical significance was determined using the unpaired 2-
tailed Student’s t test or 1-way ANOVA corrected for multiple
comparisons where appropriate. P values less than 0.05 were
considered statistically significant. All calculations were performed
using the Prism 3.0 software program for Windows (GraphPad
Software).
Results
Abdominal sepsis results in suppression of certain LPS-
induced inflammatory cytokine genes in pulmonary
macrophages
We and others have demonstrated impaired expression of
inflammatory genes from blood monocytes and tissue macrophag-
es isolated from humans with sepsis and in animal models of sepsis
[5,9,10,11,15]. To further explore the nature of LPS-inducible
genes that are dysregulated during the septic response, we induced
abdominal sepsis in mice by performing CLP or sham surgery,
then isolated pulmonary macrophages (PM) from lung digests
24 hrs after surgery. We chose the 24 hr time point post surgery,
as previous studies indicated maximum impairment in innate
responses post abdominal sepsis occurred at this time point. Lung
macrophages were incubated with LPS (1 mg/ml) or vehicle, then
RNA isolated 4 hrs post LPS administration. As shown in Figure 1,
minimal constitutive expression of the inflammatory genes TNF-a,
IL-12 p40, or iNOS was detected in vehicle treated PM isolated
from either sham of CLP animals (panels A-C). Treatment of sham
PM with LPS resulted in a substantial increase in the mRNA
expression of all of these genes. Importantly, the LPS-induced
expression of TNF-a, IL-12p40, and iNOS mRNA by PM isolated
from CLP mice was reduced by 67, 73, and .90%, respectively,
as compared to LPS-treated sham PM. In contrast, the expression
of lipocalin (Lcn2) was enhanced in PM isolated from CLP mice at
baseline, as compared to sham PM, and the expression of this gene
was further augmented in CLP PM stimulated with LPS (panel D).
The results indicate suppression of selected inflammatory genes
during sepsis, rather than global suppression of all gene products
from macrophages. Moreover, the tolerance phenotype observed
in these macrophages was transient, as LPS-induced expression of
TNF-a was progressively restored in CLP PM isolated at 3 and 7
days post CLP (panel E).
Abdominal sepsis results in alteration in activating
histone post-translational modifications in lung
macrophages
Post-translational modifications (PTM) of histones binding to
the promoters of inflammatory genes can modify the expression of
these genes. Two histone PTM generally associated with gene
activation include acetylation of histone 4 (AcH4) and trimethyla-
tion of histone 3 at lysine-4 [H3K4me3 [24,25,26,28]. To
determine if sepsis altered these activating epigenetic marks, PM
were isolated from lung digest collected 24 hrs after either sham
surgery or CLP, then incubated with vehicle or LPS ex vivo, and
acetylation and/or trimethylation of histones binding to the
murine TNF-a promoter assessed 2 hrs later by chromatin
immunoprecipitation (ChIP) analysis. Treatment of PM isolated
from sham-operated mice with LPS resulted in a considerable
increase in acetylation of histone 4 and trimethylation of the fourth
lysine residue of histone 3 (7.3-fold and 9.8-fold, respectively,
Figure 2A). Interestingly, levels of AcH4 and H3K4me3 in LPS-
treated PM isolated from CLP mice were significantly reduced
compared to sham cells. Because AcH4 and H3K4me3 function to
enhance gene transcription, in part, by facilitating binding of RNA
polymerase II to promoters of regulated genes, we next assessed
binding of RNA polymerase II to the TNF-a promoter at both 2
and 4 hrs post LPS treatment in sham and CLP macrophages. As
shown in Figure 2B, LPS induced an increase in binding of RNA
polymerase II to the TNF promoter, maximal at 2 hrs post LPS,
and declining by 4 hrs. By comparison, binding of RNA
polymerase was substantially reduced in CLP macrophages,
especially at 2 hrs post LPS.
Effect of the histone deacytylase inhibitor trichostatin
(TSA) on expression of TNF-a from PM post sham surgery
or CLP
To assess the contribution of histone deacetylases to suppression
of macrophage cytokine expression post CLP, we isolated PM
from mice 24 hrs post sham surgery or CLP, incubated cells with
the histone deacetylase (HDAC) inhibitor TSA (500 nM, Sigma)
or vehicle for one hr, followed by administration of LPS (1 mg/ml)
or vehicle. Cells were isolated 3 hrs after LPS and assessed for
acetylation of H4 at theTNF-a promoter by ChiP analysis. As
shown in Figure 3, treatment with LPS resulted in increased AcH4
in sham PM, which was diminished in PM isolated from animals
undergoing CLP. The magnitude of AcH4 was modestly but not
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TSA, as compared to sham cells treated with vehicle. However,
acetylation at H4 was significantly increased in TSA-treated CLP
macrophages over that observed in LPS-stimulated CLP PM.
Collectively, these data indicate that the reduced levels of H4
acetylation found in macrophages post CLP is due to enhanced
histone deacyetylation activity.
Abdominal sepsis results in the time dependent
expression of IRAK-M in lung macrophages
IRAK-M has previously been shown to mediate tolerance
induced by several PAMPs, including LPS and peptidoglycan
[14,16]. To determine if IRAK-M was expressed by PM during
sepsis, we measured IRAK-M mRNA and protein at various times
post CLP orsham surgery.Atbaseline,lung macrophagesexpressed
minimal amounts of IRAK-M mRNA and protein. When mice
were subjected to sham surgery, there was a modest but significant
induction of IRAK-M message by 6 hrs post surgery, with mRNA
levels returning to baseline by 24 hrs (Figure 4A). By comparison, a
greaterinduction of IRAK-MmRNA wasobserved in PM obtained
from mice undergoing CLP, with a maximal 9-fold increase over
baseline observed at 24 hrs, and returning near baseline levels by
72 hrs post CLP. Consistent with induction of IRAK-M mRNA,
therewassubstantialaccumulationofintracellularIRAK-Mprotein
inCLP PMat24 hrspost surgery,with minimal expression notedin
PM at any time post sham surgery (panel B). Treatment of PM
recovered from sham mice with LPS resulted in a 5-fold increase in
IRAK-M mRNA over baseline. However, there was a substantially
greater accumulation of IRAK-M message in CLP PM after
treatment with LPS, indicating that abdominal sepsis serves to
prime cells for augmented expression of IRAK-M in response to a
second stimulus (Figure 4, panel C).
The determine if the induction of IRAK-M in PM during
abdominal sepsis required endogenous TNF-a or live intact
bacteria, mice were pretreated with purified rabbit anti-murine
TNF-a antibody (1 mg) i.p. or the broad spectrum antibiotic
Figure 1. Effect of CLP on ex-vivo cytokine expression by control and LPS-stimulated PM. Cytokine mRNA expression was determined
4 hrs post vehicle or LPS administration by real-time PCR and expressed as fold increase over unstimulated sham PM. Panel E represents TNF-a
expression from PM collected at 1, 3, and 7 days post sham surgery or CLP. n=5 per condition, *p,0.05 as compared to sham counterpart.
doi:10.1371/journal.pone.0011145.g001
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acetylation (AcH4, panel A) and trimethylation (H3K4me3, panel B) at the TNF-a promoter 2 hrs post LPS or vehicle treatment, as determined by ChIP
analysis and expressed as percent of input DNA. Panels C and D are ChIP analyses revealing RNA polymerase II binding to the TNF-a promoter (C) and
the iNOS promoter (D) 2 and 4 hrs post LPS, and expressed as fold increase over unstimulated sham cells. Results shown represent mean of 3
separate experiments, *p,0.05 as compared to sham PM.
doi:10.1371/journal.pone.0011145.g002
Figure 3. Effect of TSA on H4 acetylation at the TNF-a promoter post CLP. Level of specific histone acetylation (AcH4) at the TNF-a promoter
4 hrs post LPS or vehicle treatment in the presence or absence of TSA, as determined by ChIP analysis and expressed as fold-increase over control.
Each condition represents pooled PM from 3 separate mice. {p,0.05 as compared to sham/LPS group, *p,0.05 as compared to CLP/LPS group.
doi:10.1371/journal.pone.0011145.g003
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isolated 24 hrs post sham surgery or CLP. To assess the
contribution of the adaptor molecule MyD88, PM were isolated
from MyD88
2/2 mice 24 hrs post CLP. As shown in Figure 4D,
the upregulation of IRAK-M mRNA in CLP PM was not
significantly altered by treatment with either anti-TNF-a neutral-
izing antibody or broad spectrum antibiotics. However, the
induction of IRAK-M mRNA after CLP was nearly completely
abolished in MyD88
2/2 mice, indicating the requirement for
MyD88 in sepsis-induced expression of IRAK-M.
IRAK-M deficient macrophages are resistant to sepsis-
induced suppression of inflammatory genes
To determine if IRAK-M contributed to sepsis-induced
suppression of inflammatory genes, we isolated PM from WT
and IRAK-M
2/2 mice 24 hrs after sham surgery or CLP, then
assessed for constitutive and LPS-stimulated expression of TNF-a
and iNOS mRNA. As observed previously, treatment of sham PM
isolated from WT mice with LPS ex vivo resulted in considerable
accumulation of TNF-a and iNOS mRNA, which was reduced in
PM isolated from WT mice undergoing CLP (Figure 5). The
constitutive expression of TNF-a and iNOS was increased in both
sham and CLP PM recovered from IRAK-M
2/2 mice, as
compared to WT PM, consistent with the previously noted
hyperinflammatory state in IRAK-M deficient macrophages.
Importantly, the LPS-induced upregulation of both TNF-a and
iNOS observed in sham PM was not significantly diminished in
IRAK-M
2/2 macrophages recovered 24 hrs post CLP, indicating
that in the absence of IRAK-M, these cells were resistant to the
development of a ‘‘tolerized’’ phenotype during sepsis.
IRAK-M deficient macrophages are relatively resistant to
sepsis-induced suppression of histone PTM and RNA
polymerase II binding
We next assessed whether or not IRAK-M mediated the alterations
in selected histone PTMs during sepsis. Treatment of WT PM with
LPS ex vivo resulted in an increase in both AcH4 and H3K4me3
binding to the TNF and iNOS promoters in PM isolated from sham
mice, whereas levels of AcH4 and H3K4me3 were diminished in PM
from WT mice isolated 24 hrs post CLP (Figure 6). In contrast, the
levels of AcH4 and H3K4me3 were largely maintained in LPS treated
PM isolated from IRAK-M
2/2mice 24 hrs post CLP as compared to
similarly-treated sham PM from IRAK-M
2/2 animals. Likewise,
binding of RNA polymerase to the TNF-a promoter was significantly
Figure 4. Induction of IRAK-M mRNA and protein after CLP or sham surgery. A. Time dependent expression of IRAK-M after CLP or sham
surgery, expressed as fold increase over baseline (time 0) mRNA expression; B. Immunoflourescence demonstrating cell-associated IRAK-M in lung
macrophages24 hrs post surgery; C. Induction of IRAK-MmRNA 24 hrs post sham surgery or CLPin untreatedandLPStreated PM ex-vivo;D. Expression
of IRAK-M mRNA in PM ex-vivo harvested from sham or CLP animals after treatment in-vivo with anti-TNF antibody or pipericillin (Pip), or in mice
deficient in MyD88 (MyD88
2/2). n= pooled cells from 3 animals per group, *p,0.05 as compared to sham, {p,0.05 as compared to other CLP groups.
doi:10.1371/journal.pone.0011145.g004
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WT sham PM (Figure S1), whereas RNA polymerase II promoter
binding was only minimally reduced in IRAK-M
2/2PM post CLP as
compared to sham IRAK-M
2/2 PM.
IRAK-M regulates the expression of HDAC-2 during sepsis
We previously showed that HDAC activity is increased in PM
post sepsis (Figure 3), and that IRAK-M regulated the magnitude of
H4 acetylation. To determine if IRAK-M regulated the expression
of Class 1 HDACs in sepsis, we isolated PM from WT and IRAK-
M
2/2 mice at 0, 6, and 24 hrs post sham surgery or CLP and
assessed for mRNA expression of HDAC-1, -2, -3, and -7. As
compared to baseline, no significant changes in the mRNA
expression of HDACs -1, -3, or -7 were noted post sepsis, and
levels of expression were similar in PM from WT and IRAK-M
2/2
mice. In contrast, a nearly 2-fold increase in levels of HDAC-2
mRNA were noted in WT PM 24 hrs post CLP. Importantly, no
induction of HDAC-2 was noted in IRAK-M deficient PM. To
confirm differences in HDAC-2 at the protein level, we performed
Westernblot analysis for HDAC-2 in PM 24 hrs post sham-surgery,
CLP, or no treatment. As compared to WT controls, HDAC-2
levels were increased in PM isolated from WT sham and especially
CLP mice (Figure 7, left panel). Under all conditions, HDAC-2
protein levels were lower in PM isolated from IRAK-M
2/2 mice
than that observed in similarly treated WT PM.
Discussion
Our findings indicate that abdominal sepsis results in
marked defects in the ability to express important innate
genes. The phenotype of lung macrophages isolated from
septic mice is analogous to that observed in endotoxin tolerized
monocyte/macrophages, whereby exposure to LPS or other
PAMPs dampen the release of inflammatory mediators upon
subsequent PAMP re-challenge [11,26,27]. We observed
suppression of several inflammatory genes, including activating
cytokines and iNOS. Similar to endotoxin-tolerized macro-
phages, we found these defects to be reversible, and noted that
some host defense genes (e.g. Lcn2) were non-tolerizable and
in fact induced in response to abdominal sepsis. The selective
inhibition of certain but not all genes is consistent with a
reprogrammed macrophage phenotype rather than a global
state of deactivation [11].
The molecular mechanisms accounting for sepsis-induced
macrophage reprogramming are almost certainly multiple. We
noted considerable induction of the TLR signaling inhibitor
IRAK-M in PM during the evolution of sepsis. The maximal
expression of this protein was coincident with the time of most
profound blunting of LPS-induced cytokine responses. More-
over, the tolerance phenotype observed in septic PM was largely
reversed in PM isolated from IRAK-M
2/2 mice, implicating
this protein as a major mediator of sepsis-induced tolerance.
IRAK-M has previously been shown to mediate macrophage
tolerance to LPS and the TLR2 agonist peptidoglycan in-vitro,
as well as tolerance responses in non-hematopoetic cells such as
biliary epithelial cells [14,18]. Interestingly, the induction of
IRAK-M during the septic response appears to be MyD88-
dependent, indicating that either TLR or IL-1 signaling
pathways induce IRAK-M in an autoregulatory fashion to
negatively regulate these inflammatory cascades. IRAK-M
Figure 5. Expression of TNF-a and iNOS mRNA from PM isolated from WT and IRAK-M
2/2 mice after sham surgery or CLP. PM were
isolated 24 hrs post sham or CLP surgery, incubated with vehicle or LPS (1 mg/ml), then mRNA expression determined by real-time PCR 4 hrs later.
n=6 per group, combined from two separate experiments. *p,0.05 as compared to WT sham, {p,0.05 as compared to WT.
doi:10.1371/journal.pone.0011145.g005
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the expression of IRAK-M is enhanced in blood monocytes
isolated from patients with sepsis, and levels in pediatric sepsis
patients directly correlate with adverse clinical outcomes in this
patient population [11,17].
Our findings indicate that sepsis resulted in remodeling of
chromatin that may provide a molecular basis for reduced
expression of selected innate genes. Specifically, we found
reduced acetylation of histone 4 and trimethylation of lysine 4 of
histone 3. Because these epigenetic marks mediate activation of
selected genes, reduced acetylation/methylation would function
to extinguish gene expression by limiting access of critical
promoter regions to transcription factors, coactivators, and
RNA polymerase. Studies performed in endotoxin-tolerized
macrophages using HDAC and demethylase inhibitors (TSA
and paragyline, respectively) suggest that reduced acetylation/
m e t h y l a t i o ni nL P St o l e r a n c ei sdue to more rapid deacetylation
and dimethylation of histones rather than impairment in initial
LPS-induced histone acetylati o na n dm e t h y l a t i o n[ 2 6 ] .I n -
creased acetylation of H4 post treatment with TSA, particularly
in PM from CLP mice, supports enhanced HDAC activity in
sepsis. Interestingly, the reduction in AcH4 and H3K4me3
observed in stimulated CLP PM was not observed in PM
isolated from IRAK-M
2/2 mice. A possible explanation for this
finding is that IRAK-M might regulate the expression of TLR-
induced HDACs or demethylases. To this end, we found a
selective increase in the expression of HDAC-2 mRNA and
protein in CLP PM isolated from WT but not IRAK-M
2/2
mice LPS has previously been shown to regulate the expression
o fc e r t a i nH D A C s ,a l t h o u g hc h a n g e si nH D A Ce x p r e s s i o n
during sepsis have not been defined [19]. Our data suggests that
I R A K - Mm a ye i t h e rd i r e c t l yo ri n d i r e c t l yi n d u c eH D A C - 2
production. The mechanism accounting for this effect is
unknown but is currently being investigated.
An alternative form of chromatin remodeling leading to gene
silencing is methylation of cysteine residues within CpG islands in
the promoter region [22]. While CpG methylation can mediate
more sustained suppression of certain genes, the promoters of
several of the inflammatory genes suppressed in sepsis, including
TNF-a, IL-6, IL-12 p40, and iNOS, contain few CpG motifs and
are therefore less susceptible to this form of epigenetic regulation.
In summary, our study shows for the first time epigenetic
changes in lung macrophages during sepsis that mimic that
observed in LPS-tolerized macrophages. IRAK-M plays a critical
role in mediating macrophage reprogramming during sepsis,
which may be due, in part, to regulation of chromatin remodeling
that controls inflammatory gene transcription. Targeting en-
zymes/proteins that modify these epigenetic changes may be a
promising approach to correcting dysregulated innate responses
in sepsis.
Figure 6. Histone modifications in PM isolated from WT and IRAK-M
2/2 mice after sham surgery or CLP. Level of specific histone
acetylation (AcH4) and trimethylation (H3K4me3) at the TNF-a promoter (A and B) and iNOS promoter (C and D) 2 hrs post LPS, as determined by
ChIP analysis and expressed as fold increase over unstimulated sham cells. Results shown represent mean of 3 separate experiments, *p,0.05 as
compared to WT sham PM treated with LPS.
doi:10.1371/journal.pone.0011145.g006
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Figure S1 RNA polymerase II promoter binding in PM isolated
from WT and IRAK-M2/2 mice after sham surgery or CLP.
Shown is binding to the TNF promoter (A) and the iNOS
promoter (B) 2 hrs post LPS, and expressed as fold increase over
resting sham PM. Results shown represent mean of 3 separate
experiments, *p,0.05 as compared to WT sham PM treated with
LPS.
Found at: doi:10.1371/journal.pone.0011145.s001 (0.04 MB TIF)
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